سعر انفلوفاك تيترا مصل سرنجة معبأة للحقن تحت الجلد 0.5 مل 2024

Influvac Tetra (Abbott; distributed by Multipharma): quadrivalent inactivated surface-antigen influenza vaccine, one 0.5 ml pre-filled syringe.

• Prophylaxis of influenza, especially in people at increased risk of complications; adults and children from 6 months; based on official recommendations.Population: Adults and children from 6 monthsWorld Health Organization (Prequalification of vaccines)

• Most frequent: injection-site pain; fatigue and headache (adults and children 6-17 years); drowsiness, irritability and loss of appetite (3-5 years); irritability (6-35 months). Reactions are usually mild and resolve in 1-3 days. Rare: allergic reactions, neuralgia, Guillain-Barre syndrome, vasculitis, transient thrombocytopenia.International label, same formulation · World Health Organization (Prequalification of vaccines)

• Hypersensitivity to the active substances, any excipient or trace residues (eggs: ovalbumin, chicken proteins; formaldehyde; cetyltrimethylammonium bromide; polysorbate 80; gentamicin). Postpone immunisation in febrile illness or acute infection.International label, same formulation · World Health Organization (Prequalification of vaccines)

• Appropriate medical treatment must be available for anaphylaxis; give with caution in thrombocytopenia or coagulation disorders (bleeding after IM injection); anxiety-related reactions including syncope may occur.International label, same formulation · World Health Organization (Prequalification of vaccines)
• Protects only against the vaccine strains and closely related strains; protective response may not occur in all vaccinees and may be insufficient in immunosuppressed patients.International label, same formulation · World Health Organization (Prequalification of vaccines)

• Immunosuppressant treatmentThe immune response may be diminished in patients receiving immunosuppressants.World Health Organization (Prequalification of vaccines)
• Serological tests (ELISA for HIV-1, hepatitis C, HTLV-1)False-positive ELISA results have been observed after influenza vaccination; Western blot disproves them.World Health Organization (Prequalification of vaccines)

• Inactivated influenza vaccines can be used in all stages of pregnancy; larger safety datasets exist for the second and third trimesters, and worldwide data do not indicate adverse fetal or maternal outcomes attributable to the vaccine.International label, same formulation · World Health Organization (Prequalification of vaccines)
• Influvac Tetra may be used during breast-feeding.International label, same formulation · World Health Organization (Prequalification of vaccines)

• Influenza virus surface antigens (haemagglutinin and neuraminidase), 4 strains: Active immunisation against two influenza A strains (H1N1, H3N2) and two influenza B strains (one from each lineage).